Online Inquiry
Cat.#: ACPP-1214
| Despition | Ki67 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1643 | Human Transthyretin Protein (AC1643) | 5 µg | inquiry |
| ACPP-1082 | Human CACYBP Protein (AC1082) | 5 µg | inquiry |
| ACPP-1721 | Human QPRT Protein (AC1721) | 5 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1362 | MERTK Blocking Peptide (AC1362) | 250 µg | inquiry |
| ACPP-1346 | GFAP Blocking Peptide (AC1346) | 250 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
| ACPP-1070 | Human Neuron Specific Enolase (Active) (AC1070) | 100 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.